METformin With a Carbohydrate Restricted Diet in Combination With Platinum Based Chemotherapy in Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer (NS-NSCLC) - METRO Study

Trial Profile

METformin With a Carbohydrate Restricted Diet in Combination With Platinum Based Chemotherapy in Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer (NS-NSCLC) - METRO Study

Recruiting
Phase of Trial: Phase II

Latest Information Update: 29 Apr 2015

At a glance

  • Drugs Metformin (Primary) ; Carboplatin; Pemetrexed
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms METRO
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 Apr 2015 Planned End Date changed from 1 Sep 2015 to 1 Sep 2017 as reported by ClinicalTrials.gov record.
    • 09 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top